Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1

• Status: Completed
• Trial end date: 1997-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is the use of buprenorphine/naloxone in treatment of opioid dependence.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Institute on Drug Abuse (NIDA)
• Collaborator: New York MDRU
• Treatments: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Naloxone

Criteria

Inclusion Criteria:

DSM-IV diagnosis of current opiate dependence males and non-pregnant, non-nursing female 18-59 yrs of age

Exclusion Criteria:

Any significant medical condition AST or ALT levels greater than 3x's the upper limit of normal level Current Axis I diagnosis other than opiate, caffeine or nicotine dependence